# The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity

> **NCT02896309** · NA · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 45 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Sodium bicarbonate
- **DIETARY_SUPPLEMENT:** Sodium chloride

## Key facts

- **NCT ID:** NCT02896309
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-12-27
- **Final completion:** 2018-12-27
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02896309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02896309, "The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02896309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*